Cell Therapy Stocks List

Recent Signals

Date Stock Signal Type
2021-06-11 ALLO Crossed Above 20 DMA Bullish
2021-06-11 ALLO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-06-11 ALVR MACD Bearish Signal Line Cross Bearish
2021-06-11 ALVR Doji - Bullish? Reversal
2021-06-11 BCDA Calm After Storm Range Contraction
2021-06-11 BCDA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-06-11 BCDA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-06-11 BLCM Stochastic Sell Signal Bearish
2021-06-11 CGEM Calm After Storm Range Contraction
2021-06-11 CGEM Fell Below 50 DMA Bearish
2021-06-11 CLBS Bollinger Band Squeeze Range Contraction
2021-06-11 CLBS Upper Bollinger Band Walk Strength
2021-06-11 CLBS NR7 Range Contraction
2021-06-11 CLBS Narrow Range Bar Range Contraction
2021-06-11 IMTX NR7 Range Contraction
2021-06-11 IOVA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-06-11 IOVA Pocket Pivot Bullish Swing Setup
2021-06-11 IOVA Stochastic Reached Overbought Strength
2021-06-11 LEGN MACD Bearish Signal Line Cross Bearish
2021-06-11 MRKR New 52 Week Closing High Bullish
2021-06-11 ORGS 200 DMA Support Bullish
2021-06-11 ORGS Upper Bollinger Band Walk Strength
2021-06-11 PSTI Shooting Star Candlestick Bearish
2021-06-11 PSTI Upper Bollinger Band Walk Strength
2021-06-11 PSTI Calm After Storm Range Contraction
2021-06-11 PSTI Doji - Bearish? Reversal
2021-06-11 SQZ NR7 Range Contraction
2021-06-11 SQZ 20 DMA Support Bullish
2021-06-11 SQZ Bollinger Band Squeeze Range Contraction
2021-06-11 TALS Hot IPO Pullback Bullish Swing Setup
2021-06-11 TIL 20 DMA Resistance Bearish
2021-06-11 VCEL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-06-11 VCEL Narrow Range Bar Range Contraction
2021-06-11 VCEL NR7 Range Contraction

Cell Therapy Stocks Recent News

Date Stock Title
Jun 13 BLCM Should I Avoid Bellicum Pharmaceuticals Inc (BLCM)?
Jun 11 LCTX Updated OpRegen Data Looks Promising For Lineage
Jun 10 IOVA Anthem downgraded while Community Health and Pennant upgraded at RBC, and more in analyst action
Jun 10 LGVN Longeveron’s Chairman and Chief Science Officer Invited by National Academy of Medicine to Speak at Longevity Symposium
Jun 10 ORGS Orgenesis announces use of the Tissue Genesis Icellator® in a Hospital for Special Surgery clinical study for rotator cuff repair
Jun 9 SQZ Preclinical data shows SQZ cell line platform may treat autoimmune diseases
Jun 9 SQZ The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Jun 9 VCEL Vericel to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021
Jun 9 LCTX Lineage Cell to join Russell 3000 and Microcap index
Jun 9 SQZ SQZ Biotechnologies' TAC Program Induces Multiple Mechanisms Of Antigen-Specific Tolerance, Animal Study Shows
Jun 9 LCTX Lineage Cell Therapeutics Set to Join Russell 3000® Index and Russell Microcap® Index
Jun 9 SQZ SQZ Biotechnologies Tolerizing Antigen Carrier (TAC) Program Induces Antigen-Specific Immune Tolerance in Preclinical Models Demonstrating Potential for Broad Applicability Across Autoimmune Diseases
Jun 8 TALS The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
Jun 8 ALLO The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
Jun 8 PSTI Cathie Wood Sells $26M In DocuSign Days After Spelling Bull Case, Also Sheds $6M In Snapchat
Jun 7 ALLO The Bottom Is in for These 3 Stocks? Analysts Say ‘Buy’
Jun 7 CGEM Cullinan Gets FDA Investigational Clearance for Leukemia Drug
Jun 7 CGEM Cullinan (CGEM) Rises on Promising Phase I Cancer Study Data
Jun 7 CGEM Cullinan Oncology shares rise on FDA's CLN-049 IND clearance
Jun 7 CGEM Cullinan Oncology Receives Investigational New Drug (IND) Clearance from the FDA for CLN-049, a FLT3 x CD3 Bispecific Antibody for the Treatment of Relapsed/Refractory AML
Related Industries: Biotechnology Other

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

More about Cell Therapy
Browse All Tags